MARAGANORE JOHN, Director at TAKEDA PHARMACEUTICAL CO LTD, traded $5.7M of TAK
This page documents an SEC Form 4 insider trading disclosure for $TAK securities filed with the Securities and Exchange Commission. Section 16 of the Securities Exchange Act of 1934 mandates that corporate officers, directors, and beneficial owners of more than 10% of a company's registered equity securities must report their personal trades within two business days of execution. Insider transactions are closely monitored by market participants because insiders possess firsthand knowledge of company operations, financial condition, and near-term prospects. The transaction details below are drawn directly from the SEC EDGAR filing database and reflect the information as reported.
Transaction Details
| Insider | MARAGANORE JOHN |
|---|---|
| Title | Director |
| Company | TAKEDA PHARMACEUTICAL CO LTD |
| Ticker | TAK |
| Transaction Type | Disposition |
| Transaction Date | 2026-07-10 |
| Shares Traded | 1,152 |
| Price Per Share | $4,931.2 |
| Total Value | $5.7M |
| Filed Date | 2026-07-06 |
| Accession Number | 0001395064-26-000275 |
Ownership Context
| Shares Owned After Transaction | — |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001395064-26-000275
Other Insider Trades — TAK
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Reed Kimberly A. | Director | traded | $5.7M | 2026-07-10 |
| Miyabashira Asuka | President, Japan Pharma B.U. | traded | $5.0M | 2026-07-10 |
| Tsusaka Miki | Director | traded | $10.6M | 2026-07-10 |
| GILLIS STEVEN | Director | traded | $5.7M | 2026-07-10 |
| Furuta Milano | Chief Financial Officer, Director | traded | $82.0M | 2026-07-10 |
| Iijima Masami | Director | traded | $10.6M | 2026-07-10 |
| Platford Giles Richard | President, IBU | traded | — | 2026-07-01 |
| Plump Andrew Stewart | President, R&D, Director | traded | — | 2026-07-01 |
| Smoter Jennifer Marie | Chief Comm. & Gov. Officer | traded | — | 2026-07-01 |
| Kim Julie So-Young | President and CEO, Director | traded | — | 2026-07-01 |
Other Trades by MARAGANORE JOHN
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| TAK | TAKEDA PHARMACEUTICAL CO LTD | traded | — | 2026-07-01 |
| TAK | TAKEDA PHARMACEUTICAL CO LTD | traded | — | 2026-07-01 |
| KYMR | Kymera Therapeutics, Inc. | traded | — | 2026-06-24 |
| RAPP | Rapport Therapeutics, Inc. | traded | — | 2026-06-10 |
| BEAM | Beam Therapeutics Inc. | traded | — | 2026-06-03 |
| COAG | Hemab Therapeutics Holdings, Inc. | traded | — | 2026-05-04 |
| COAG | Hemab Therapeutics Holdings, Inc. | traded | — | 2026-05-04 |
| COAG | Hemab Therapeutics Holdings, Inc. | traded | — | 2026-01-29 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for TAK — TAKEDA PHARMACEUTICAL CO LTD →
Whisper Score — TAK
Track TAK insider activity in real time on The Wire →
Get alerts when MARAGANORE JOHN files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: August 12, 2026 at 07:07 UTC